Evidence map›Paper›PMID 31302751›Full record

ArticleCellular and molecular life sciences : CMLS2020

Molecular characterization of an aquaporin-2 mutation causing a severe form of nephrogenic diabetes insipidus.

Emel Saglar Ozer, Hanne B Moeller, Tugce Karaduman, Robert A Fenton, Hatice Mergen

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Comprehensive assessment of side effects in COVID-19 drug pipeline from a network perspective.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Emel Saglar OzerDepartment of Biology, Faculty of Science, Hacettepe University, 06800, Ankara, Turkey. esaglar@hacettepe.edu.tr.ORCID http://orcid.org/0000-0002-8161-827X
Hanne B MoellerDepartment of Biomedicine, Aarhus University, South, Bldg 1233, 3 Wilhelm Meyers Alle, 8000, Aarhus, Denmark. HBMO@biomed.au.dk.ORCID http://orcid.org/0000-0001-9427-0279
Tugce KaradumanDepartment of Biology, Faculty of Science, Hacettepe University, 06800, Ankara, Turkey.ORCID http://orcid.org/0000-0003-0728-0968
Robert A FentonDepartment of Biomedicine, Aarhus University, South, Bldg 1233, 3 Wilhelm Meyers Alle, 8000, Aarhus, Denmark.ORCID http://orcid.org/0000-0003-1623-199X
Hatice MergenDepartment of Biology, Faculty of Science, Hacettepe University, 06800, Ankara, Turkey.ORCID http://orcid.org/0000-0002-7980-8197
Hacettepe University · TRAarhus University · DK

Funding

The European Molecular Biology Organisation (EMBO) ASFT No: 583-2014The Scientific and Technological Research Council of Turkey 115S499
6 · The paper itself

Abstract

The water channel aquaporin 2 (AQP2) is responsible for water reabsorption by kidney collecting duct cells. A substitution of amino acid leucine 137 to proline in AQP2 (AQP2-L137P) causes Nephrogenic Diabetes Insipidus (NDI). This study aimed to determine the cell biological consequences of this mutation on AQP2 function. Studies were performed in HEK293 and MDCK type I cells, transfected with wildtype (WT) AQP2 or an AQP2-L137P mutant. AQP2-L137P was predominantly detected as a high-mannose form of AQP2, whereas AQP2-WT was observed in both non-glycosylated and complex glycosylated forms. In contrast to AQP2-WT, the AQP2-L137P mutant did not accumulate on the apical plasma membrane following stimulation with forskolin. Ubiquitylation of AQP2-L137P was different from AQP2-WT, with predominance of non-distinct protein bands at various molecular weights. The AQP2-L137P mutant displayed reduced half-life compared to AQP2-WT. Treatment of cells with chloroquine increased abundance of AQP2-WT, but not AQP2-L137P. In contrast, treatment with MG132 increased abundance of AQP2-L137P but not AQP2-WT. Xenopus oocytes injected with AQP2-WT had increased osmotic water permeability when compared to AQP2-L137P, which correlated with lack of the mutant form in the plasma membrane. From the localization of the mutation and nature of the substitution it is likely that AQP2-L137P causes protein misfolding, which may be responsible for the observed functional defects. The data suggest that the L137P mutation results in altered AQP2 protein maturation, increased AQP2 degradation via the proteasomal pathway and limited plasma membrane expression. These combined mechanisms are likely responsible for the phenotype observed in this class of NDI patients.

Indexed as

AnimalsAquaporin 2Cell LineCell Membrane PermeabilityChloroquineDiabetes Insipidus, NephrogenicDogsHEK293 CellsHumansKidney Tubules, CollectingLeupeptinsMadin Darby Canine Kidney CellsOocytesProtein FoldingProteostasis DeficienciesUbiquitinationAQP2 protein, humanAquaporin 2benzyloxycarbonylleucyl-leucyl-leucine aldehydeChloroquineLeupeptinsAquaporin 2MutationNephrogenic diabetes insipidusWater channelXenopus oocytes

Identifiers

PMID31302751
PMCPMC11104860
OpenAlexW2962356165

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.